Mitoxantrone Recruiting Phase 3 Trials for Pediatric Acute Myeloblastic Leukemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01828489Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years